Skip to main content
SpringerLink
Log in
Book cover

Advances in multiple Sclerosis and Experimental Demyelinating Diseases pp 45–72Cite as

Multiple Sclerosis Genetics

  • Chapter

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 318))

Multiple sclerosis (MS) clusters with the so-called complex genetic diseases, a group of common disorders characterized by modest disease risk heritability and multifaceted gene-environment interactions. The major histocompatibility complex (MHC) is the only genomic region consistently associated with MS, and susceptible MHC haplotypes have been identified. Although the MHC does not account for all genetic contribution to MS, the other genetic contributors have been elusive. Microarray gene-expression studies, which also have not identified a major MS locus, have, however, been promising in elucidating some of the possible pathways involved in the disease. Yet, microarray studies thus far have been unable to separate the genetic causes of MS from the expression consequences of MS. The use of new methodologies and technologies to refine the phenotype, such as brain spectroscopy, PET and functional magnetic resonance imaging combined with novel computational tools and a better understanding of the human genome architecture, may help resolve the genetic causes of MS.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abdeen H, Heggarty S, Hawkins SA, Hutchinson M, McDonnell GV, Graham CA (2006) Mapping candidate non-MHC susceptibility regions to multiple sclerosis. Genes Immun 7:494-502

    CAS  PubMed  Google Scholar 

  2. Achiron A and Gurevich M (2006) Peripheral blood gene expression signature mirrors central nervous system disease: the model of multiple sclerosis. Autoimmun Rev 5(8):517-522

    CAS  PubMed  Google Scholar 

  3. Achiron A, Gurevich M, Friedman N, Kaminski N and Mandel M (2004) Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity. Ann Neurol 55(3):410-417

    CAS  PubMed  Google Scholar 

  4. Akesson E, Coraddu F, Marrosu MG, Massacesi L, Hensiek A, Harbo HF, Oturai A, Trojano M, Momigliano-Richiardi P, Cocco E, Murru R, Hillert J, Compston A, Sawcer S (2003) Refining the linkage analysis on chromosome 10 in 449 sib-pairs with multiple sclerosis. J Neuroimmunol 143:31-38

    CAS  PubMed  Google Scholar 

  5. Akesson E, Oturai A, Berg J, Fredrikson S, Andersen O, Harbo HF, Laaksonen M, Myhr KM, Nyland HI, Ryder LP, Sandberg-Wollheim M, Sorensen PS, Spurkland A, Svejgaard A, Holmans P, Compston A, Hillert J, Sawcer S (2002) A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis. Genes Immun 3:279-285

    CAS  PubMed  Google Scholar 

  6. Alizadeh M, Genin E, Babron MC, Birebent B, Cournu-Rebeix I, Yaouanq J, Dreano S, Sawcer S, Compston A, Clanet M, Edan G, Fontaine B, Clerget-Darpoux F, Semana G (2003) Genetic analysis of multiple sclerosis in Europeans: French data. J Neuroimmunol 143:74-78

    CAS  PubMed  Google Scholar 

  7. Allen M, Sandberg-Wollheim M, Sjogren K, Erlich HA, Petterson U, Gyllensten U (1994) Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol 39:41-48

    CAS  PubMed  Google Scholar 

  8. Alter M, Halpern L, Kurland LT, Bornstein B, Leibowitz U, Silberstein J (1962) Multiple sclerosis in Israel. Prevalence among immigrants and native inhabitants. Arch Neurol 7:253-263

    CAS  PubMed  Google Scholar 

  9. Ban M, Sawcer SJ, Heard RN, Bennetts BH, Adams S, Booth D, Perich V, Setakis E, Compston A, Stewart GJ (2003) A genome-wide screen for linkage disequilibrium in Australian HLA-DRB1*1501 positive multiple sclerosis patients. J Neuroimmunol 143:60-64

    CAS  PubMed  Google Scholar 

  10. Ban M, Stewart GJ, Bennetts BH, Heard R, Simmons R, Maranian M, Compston A, Sawcer SJ (2002) A genome screen for linkage in Australian sibling-pairs with multiple sclerosis. Genes Immun 3:464-469

    CAS  PubMed  Google Scholar 

  11. Baranzini SE, Mousavi P, Rio J, Caillier SJ, Stillman A, Villoslada P, Wyatt MM, Comabella M, Greller LD, Somogyi R, Montalban X, Oksenberg JR (2005) Transcription-based prediction of response to IFNbeta using supervised computational methods. PLoS Biol 3:e2

    Google Scholar 

  12. Barcellos LF, Begovich AB, Reynolds RL, Caillier SJ, Brassat D, Schmidt S, Grams SE, Walker K, Steiner LL, Cree BA, Stillman A, Lincoln RR, Pericak-Vance MA, Haines JL, Erlich HA, Hauser SL, Oksenberg JR (2004) Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis. Ann Neurol 55:793-800

    CAS  PubMed  Google Scholar 

  13. Barcellos LF, Oksenberg JR, Begovich AB, Martin ER, Schmidt S, Vittinghoff E, Goodin DS, Pelletier D, Lincoln RR, Bucher P, Swerdlin A, Pericak-Vance MA, Haines JL, Hauser SL (2003) HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet 72:710-716

    CAS  PubMed  Google Scholar 

  14. Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F, Cree BC, Begovich AB, Villoslada P, Montalban X, Uccelli A, Savettieri G, Lincoln RR, DeLoa C, Haines JL, Pericak-Vance MA, Compston A, Hauser SL, Oksenberg JR (2006) Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 15:2813-2824

    CAS  PubMed  Google Scholar 

  15. Barcellos LF, Thomson G, Carrington M, Schafer J, Begovich AB, Lin P, Xu XH, Min BQ, Marti D, Klitz W (1997) Chromosome 19 single-locus and multilocus haplotype associations with multiple sclerosis. Evidence of a new susceptibility locus in Caucasian and Chinese patients. JAMA 278:1256-1261

    CAS  PubMed  Google Scholar 

  16. Bielecki B, Mycko MP, Tronczynska E, Bieniek M, Sawcer S, Setakis E, Benediktsson K, Compston A, Selmaj KW (2003) A whole genome screen for association in Polish multiple sclerosis patients. J Neuroimmunol 143:107-111

    CAS  PubMed  Google Scholar 

  17. Bomprezzi R, Ringner M, Kim S, Bittner ML, Khan J, Chen Y, Elkahloun A, Yu A, Bielekova B, Meltzer PS, Martin R, McFarland HF, Trent JM (2003) Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum Mol Genet 12:2191-2199

    CAS  PubMed  Google Scholar 

  18. Boon M, Nolte IM, Bruinenberg M, Spijker GT, Terpstra P, Raelson J, De Keyser J, Zwanikken CP, Hulsbeek M, Hofstra RM, Buys CH, te Meerman GJ (2001) Mapping of a susceptibility gene for multiple sclerosis to the 51 kb interval between G511525 and D6S1666 using a new method of haplotype sharing analysis. Neurogenetics 3:221-230

    CAS  PubMed  Google Scholar 

  19. Brassat D, Motsinger AA, Caillier SJ, Erlich HA, Walker K, Steiner LL, Cree BA, Barcellos LF, Pericak-Vance MA, Schmidt S, Gregory S, Hauser SL, Haines JL, Oksenberg JR, Ritchie MD (2006) Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African Americans. Genes Immun 7:310-315

    CAS  PubMed  Google Scholar 

  20. Broadley S, Sawcer S, D’Alfonso S, Hensiek A, Coraddu F, Gray J, Roxburgh R, Clayton D, Buttinelli C, Quattrone A, Trojano M, Massacesi L, Compston A (2001) A genome screen for multiple sclerosis in Italian families. Genes Immun 2:205-210

    CAS  PubMed  Google Scholar 

  21. Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, Sobel RA, Lock C, Karpuj M, Pedotti R, Heller R, Oksenberg JR, Steinman L (2001) The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294:1731-1735

    CAS  PubMed  Google Scholar 

  22. Chataway J, Feakes R, Coraddu F, Gray J, Deans J, Fraser M, Robertson N, Broadley S, Jones H, Clayton D, Goodfellow P, Sawcer S, Compston A (1998) The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. Brain 121:1869-1887

    PubMed  Google Scholar 

  23. Chataway J, Sawcer S, Feakes R, Coraddu F, Broadley S, Jones HB, Clayton D, Gray J, Goodfellow PN, Compston A (1999) A screen of candidates from peaks of linkage: evidence for the involvement of myeloperoxidase in multiple sclerosis. J Neuroimmunol 98:208-213

    CAS  PubMed  Google Scholar 

  24. Coraddu F, Lai M, Mancosu C, Cocco E, Sawcer S, Setakis E, Compston A, Marrosu MG (2003) A genome-wide screen for linkage disequilibrium in Sardinian multiple sclerosis. J Neuroimmunol 143:120-123

    CAS  PubMed  Google Scholar 

  25. Coraddu F, Sawcer S, D’Alfonso S, Lai M, Hensiek A, Solla E, Broadley S, Mancosu C, Pugliatti M, Marrosu MG, Compston A (2001) A genome screen for multiple sclerosis in Sardinian multiplex families. Eur J Hum Genet 9:621-626

    CAS  PubMed  Google Scholar 

  26. Cunningham S, Patterson CC, McDonnell G, Hawkins S, Vandenbroeck K (2005) Haplotype analysis of the preprotachykinin-1 (TAC1) gene in multiple sclerosis. Genes Immun 6:265-270

    CAS  PubMed  Google Scholar 

  27. D’Alfonso S, Nistico L, Bocchio D, Bomprezzi R, Marrosu MG, Murru MR, Lai M, Massacesi L, Ballerini C, Repice A, Salvetti M, Montesperelli C, Ristori G, Trojano M, Liguori M, Gambi D, Quattrone A, Tosi R, Momigliano-Richiardi P (2000) An attempt of identifying MS-associated loci as a follow-up of a genomic linkage study in the Italian population. J Neurovirol 6 [Suppl 2]: S18-S22

    PubMed  Google Scholar 

  28. D’Alfonso S, Nistico L, Zavattari P, Marrosu MG, Murru R, Lai M, Massacesi L, Ballerini C, Gestri D, Salvetti M, Ristori G, Bomprezzi R, Trojano M, Liguori M, Gambi D, Quattrone A, Fruci D, Cucca F, Richiardi PM, Tosi R (1999) Linkage analysis of multiple sclerosis with candidate region markers in Sardinian and Continental Italian families. Eur J Hum Genet 7:377-385

    PubMed  Google Scholar 

  29. de Jong BA, Huizinga TW, Zanelli E, Giphart MJ, Bollen EL, Uitdehaag BM, Polman CH, Westendorp RG (2002) Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region. Neurology 59:549-555

    CAS  PubMed  Google Scholar 

  30. Dean G (1967) Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa. BMJ 2:724-730

    CAS  PubMed  Google Scholar 

  31. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461-1463

    CAS  PubMed  Google Scholar 

  32. Dutta R, McDonough J, Yin X, Peterson J, Chang A, Torres T, Gudz T, Macklin WB, Lewis DA, Fox RJ, Rudick R, Mirnics K, Trapp BD (2006) Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 59:478-489

    CAS  PubMed  Google Scholar 

  33. Dyment DA, Herrera BM, Cader MZ, Willer CJ, Lincoln MR, Sadovnick AD, Risch N, Ebers GC (2005) Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet 14:2019-2026

    CAS  PubMed  Google Scholar 

  34. Dyment DA, Sadovnick AD, Willer CJ, Armstrong H, Cader ZM, Wiltshire S, Kalman B, Risch N, Ebers GC (2004) An extended genome scan in 442 Canadian multiple sclerosisaffected sibships: a report from the Canadian Collaborative Study Group. Hum Mol Genet 13:1005-1015

    CAS  PubMed  Google Scholar 

  35. Dyment DA, Willer CJ, Scott B, Armstrong H, Ligers A, Hillert J, Paty DW, Hashimoto S, Devonshire V, Hooge J, Kastrukoff L, Oger J, Metz L, Warren S, Hader W, Power C, Auty A, Nath A, Nelson R, Freedman M, Brunet D, Paulseth JE, Rice G, O’Connor P, Duquette P, Lapierre Y, Francis G, Bouchard JP, Murray TJ, Bhan V, Maxner C, Pryse-Phillips W, Stefanelli M, Sadovnick AD, Risch N, Ebers GC (2001) Genetic susceptibility to MS: a second stage analysis in Canadian MS families. Neurogenetics 3:145-151

    CAS  PubMed  Google Scholar 

  36. Ebers GC, Kukay K, Bulman DE, Sadovnick AD, Rice G, Anderson C, Armstrong H, Cousin K, Bell RB, Hader W, Paty DW, Hashimoto S, Oger J, Duquette P, Warren S, Gray T, O’Connor P, Nath A, Auty A, Metz L, Francis G, Paulseth JE, Murray TJ, Pryse-Phillips W, Nelson R, Freedman M, Brunet D, Bouchard JP, Hinds D, Risch N (1996) A full genome search in multiple sclerosis. Nat Genet 13:472-476

    CAS  PubMed  Google Scholar 

  37. Ebers GC, Sadovnick AD, Risch NJ (1995) A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 377:150-151

    CAS  PubMed  Google Scholar 

  38. Eraksoy M, Hensiek A, Kurtuncu M, Akman-Demir G, Kilinc M, Gedizlioglu M, PetekBalci B, Anlar O, Kutlu C, Saruhan-Direskeneli G, Idrisoglu HA, Setakis E, Compston A, Sawcer S (2003a) A genome screen for linkage disequilibrium in Turkish multiple sclerosis. J Neuroimmunol 143:129-132

    CAS  Google Scholar 

  39. Eraksoy M, Kurtuncu M, Akman-Demir G, Kilinc M, Gedizlioglu M, Mirza M, Anlar O, Kutlu C, Demirkiran M, Idrisoglu HA, Compston A, Sawcer S (2003b) A whole genome screen for linkage in Turkish multiple sclerosis. J Neuroimmunol 143:17-24

    CAS  Google Scholar 

  40. Fedetz M, Matesanz F, Caro-Maldonado A, Fernandez O, Tamayo JA, Guerrero M, Delgado C, Lopez-Guerrero JA, Alcina A (2006) OAS1 gene haplotype confers susceptibility to multiple sclerosis. Tissue Antigens 68:446-449

    CAS  PubMed  Google Scholar 

  41. Fernald GH, Yeh RF, Hauser SL, Oksenberg JR, Baranzini SE (2005) Mapping gene activity in complex disorders: integration of expression and genomic scans for multiple sclerosis. J Neuroimmunol 167:157-169

    CAS  PubMed  Google Scholar 

  42. Fernandez O, Fernandez V, Alonso A, Caballero A, Luque G, Bravo M, Leon A, Mayorga C, Leyva L, de Ramon E (2004) DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain. J Neurol 251:440-444

    CAS  Google Scholar 

  43. Feuk L, Marshall CR, Wintle RF, Scherer SW (2006) Structural variants: changing the landscape of chromosomes and design of disease studies. Hum Mol Genet 15 Spec No 1: R57-R66

    Google Scholar 

  44. Fogdell-Hahn A, Ligers A, Gronning M, Hillert J, Olerup O (2000) Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 55:140-148

    CAS  PubMed  Google Scholar 

  45. Fukazawa T, Kikuchi S, Miyagishi R, Miyazaki Y, Yabe I, Hamada T, Sasaki H (2006) HLA-dPB1*0501 is not uniquely associated with opticospinal multiple sclerosis in Japanese patients. Important role of DPB1*0301. Mult Scler 12:19-23

    CAS  PubMed  Google Scholar 

  46. GAMES and Cooperative TMSG (2003) A meta-analysis of whole genome linkage screens in multiple sclerosis. J Neuroimmunol 143:39-46

    Google Scholar 

  47. Giedraitis V, Modin H, Callander M, Landtblom AM, Fossdal R, Stefansson K, Hillert J, Gulcher J (2003) Genome-wide TDT analysis in a localized population with a high prevalence of multiple sclerosis indicates the importance of a region on chromosome 14q. Genes Immun 4:559-563

    CAS  PubMed  Google Scholar 

  48. Goedde R, Sawcer S, Boehringer S, Miterski B, Sindern E, Haupts M, Schimrigk S, Compston A, Epplen JT (2002) A genome screen for linkage disequilibrium in HLADRB1*15-positive Germans with multiple sclerosis based on 4666 microsatellite markers. Hum Genet 111:270-277

    CAS  PubMed  Google Scholar 

  49. Goertsches R, Villoslada P, Comabella M, Montalban X, Navarro A, de la Concha EG, Arroyo R, Lopez de Munain A, Otaegui D, Palacios R, Perez-Tur J, Jonasdottir A, Benediktsson K, Fossdal R, Sawcer S, Setakis E, Compston A (2003) A genomic screen of Spanish multiple sclerosis patients reveals multiple loci associated with the disease. J Neuroimmunol 143:124-128

    CAS  PubMed  Google Scholar 

  50. Goris A, Maranian M, Walton A, Yeo TW, Ban M, Gray J, Compston A, Sawcer S (2006) No evidence for association of a European-specific chromosome 17 inversion with multiple sclerosis. Eur J Hum Genet 14:1064

    CAS  PubMed  Google Scholar 

  51. Goris A, Sawcer S, Vandenbroeck K, Carton H, Billiau A, Setakis E, Compston A, Dubois B (2003) New candidate loci for multiple sclerosis susceptibility revealed by a whole genome association screen in a Belgian population. J Neuroimmunol 143:65-69

    CAS  PubMed  Google Scholar 

  52. Gregory, SG, Schmidt S, Seth P, Oksenberg JR, Hart J, Prokop A, Caillier SJ, Ban M, Goris A, Barcellos LF, Lincoln R, McCauley JL, Sawcer SJ, Compston DA, Dubois B, Hauser SL, Garcia-Blanco MA, Pericak-Vance MA, and Haines JL (2007) Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 39:1083-1091

    CAS  PubMed  Google Scholar 

  53. Gregersen JW, Kranc KR, Ke X, Svendsen P, Madsen LS, Thomsen AR, Cardon LR, Bell JI, Fugger L (2006) Functional epistasis on a common MHC haplotype associated with multiple sclerosis. Nature 443:574-577

    CAS  PubMed  Google Scholar 

  54. Haines JL, Bradford Y, Garcia ME, Reed AD, Neumeister E, Pericak-Vance MA, Rimmler JB, Menold MM, Martin ER, Oksenberg JR, Barcellos LF, Lincoln R, Hauser SL (2002) Multiple susceptibility loci for multiple sclerosis. Hum Mol Genet 11:2251-2256

    CAS  PubMed  Google Scholar 

  55. Haines JL, Ter-Minassian M, Bazyk A, Gusella JF, Kim DJ, Terwedow H, Pericak-Vance MA, Rimmler JB, Haynes CS, Roses AD, Lee A, Shaner B, Menold M, Seboun E, Fitoussi RP, Gartioux C, Reyes C, Ribierre F, Gyapay G, Weissenbach J, Hauser SL, Goodkin DE, Lincoln R, Usuku K, Oksenberg JR et al (1996) A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat Genet 13:469-471

    CAS  PubMed  Google Scholar 

  56. Haines JL, Terwedow HA, Burgess K, Pericak-Vance MA, Rimmler JB, Martin ER, Oksenberg JR, Lincoln R, Zhang DY, Banatao DR, Gatto N, Goodkin DE, Hauser SL (1998) Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. Hum Mol Genet 7:1229-1234

    CAS  PubMed  Google Scholar 

  57. Harbo HF, Datta P, Oturai A, Ryder LP, Sawcer S, Setakis E, Akesson E, Celius EG, Modin H, Sandberg-Wollheim M, Myhr KM, Andersen O, Hillert J, Sorensen PS, Svejgaard A, Compston A, Vartdal F, Spurkland A (2003) Two genome-wide linkage disequilibrium screens in Scandinavian multiple sclerosis patients. J Neuroimmunol 143:101-106

    CAS  PubMed  Google Scholar 

  58. Heggarty S, Sawcer S, Hawkins S, McDonnell G, Droogan A, Vandenbroeck K, Hutchinson M, Setakis E, Compston A, Graham C (2003) A genome-wide scan for association with multiple sclerosis in a N. Irish case control population. J Neuroimmunol 143:93-96

    CAS  PubMed  Google Scholar 

  59. Hensiek AE, Roxburgh R, Smilie B, Coraddu F, Akesson E, Holmans P, Sawcer SJ, Compston DA (2003) Updated results of the United Kingdom linkage-based genome screen in multiple sclerosis. J Neuroimmunol 143:25-30

    CAS  PubMed  Google Scholar 

  60. Hur EM, Youssef S, Haws ME, Zhang SY, Sobel RA, Steinman L (2007) Osteopontininduced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat Immunol 8:74-83

    CAS  PubMed  Google Scholar 

  61. Ito H, Yamasaki K, Kawano Y, Horiuchi I, Yun C, Nishimura Y, Kira J (1998) HLA-DPassociated susceptibility to the optico-spinal form of multiple sclerosis in the Japanese. Tissue Antigens 52:179-182

    CAS  PubMed  Google Scholar 

  62. Jansen RC, Nap JP (2001) Genetical genomics: the added value from segregation. Trends Genet 17:388-391

    CAS  PubMed  Google Scholar 

  63. Jonasdottir A, Thorlacius T, Fossdal R, Jonasdottir A, Benediktsson K, Benedikz J, Jonsson HH, Sainz J, Einarsdottir H, Sigurdardottir S, Kristjansdottir G, Sawcer S, Compston A, Stefansson K, Gulcher J (2003) A whole genome association study in Icelandic multiple sclerosis patients with 4804 markers. J Neuroimmunol 143:88-92

    CAS  PubMed  Google Scholar 

  64. Kenealy SJ, Babron MC, Bradford Y, Schnetz-Boutaud N, Haines JL, Rimmler JB, Schmidt S, Pericak-Vance MA, Barcellos LF, Lincoln RR, Oksenberg JR, Hauser SL, Clanet M, Brassat D, Edan G, Yaouanq J, Semana G, Cournu-Rebeix I, Lyon-Caen O, Fontaine B (2004) A second-generation genomic screen for multiple sclerosis. Am J Hum Genet 75:1070-1078

    CAS  PubMed  Google Scholar 

  65. Kira J (2003) Multiple sclerosis in the Japanese population. Lancet Neurol 2(2):117-127

    PubMed  Google Scholar 

  66. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308:385-389

    CAS  PubMed  Google Scholar 

  67. Kuokkanen S, Gschwend M, Rioux JD, Daly MJ, Terwilliger JD, Tienari PJ, Wikstrom J, Palo J, Stein LD, Hudson TJ, Lander ES, Peltonen L (1997) Genomewide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet 61:1379-1387

    CAS  PubMed  Google Scholar 

  68. Kurtzke JF, Hyllested K (1987) MS epidemiology in Faroe Islands. Riv Neurol 57:77-87

    CAS  PubMed  Google Scholar 

  69. Laaksonen M, Jonasdottir A, Fossdal R, Ruutiainen J, Sawcer S, Compston A, Benediktsson K, Thorlacius T, Gulcher J, Ilonen J (2003) A whole genome association study in Finnish multiple sclerosis patients with 3669 markers. J Neuroimmunol 143:70-73

    CAS  PubMed  Google Scholar 

  70. Larsen F, Oturai A, Ryder LP, Madsen HO, Hillert J, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Harbo HF, Sawcer S, Fugger L, Sorensen PS, Svejgaard A (2000) Linkage analysis of a candidate region in Scandinavian sib pairs with multiple sclerosis reveals linkage to chromosome 17q. Genes Immun 1:456-459

    CAS  PubMed  Google Scholar 

  71. Lie BA, Akselsen HE, Bowlus CL, Gruen JR, Thorsby E, Undlien DE (2002) Polymorphisms in the gene encoding thymus-specific serine protease in the extended HLA complex: a potential candidate gene for autoimmune and HLA-associated diseases. Genes Immun 3:306-312

    CAS  PubMed  Google Scholar 

  72. Ligers A, Dyment DA, Willer CJ, Sadovnick AD, Ebers G, Risch N, Hillert J (2001) Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis. Am J Hum Genet 69:900-903

    CAS  PubMed  Google Scholar 

  73. Liguori M, Sawcer S, Setakis E, Compston A, Giordano M, D’Alfonso S, Mellai M, Malferrari G, Trojano M, Livrea P, De Robertis F, Massacesi L, Repice A, Ballerini C, Biagioli T, Bomprezzi R, Cannoni S, Ristori G, Salvetti M, Grimaldi LM, Biunno I, Comi G, Leone M, Ferro I, Naldi P, Milanese C, Gellera C, Loredana LM, Savettieri G, Salemi G, Aridon P, Caputo D, Rosa Guerini F, Ferrante P, Momigliano-Richiardi P (2003) A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population. J Neuroimmunol 143:97-100

    CAS  PubMed  Google Scholar 

  74. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J, Klonowski P, Austin A, Lad N, Kaminski N, Galli SJ, Oksenberg JR, Raine CS, Heller R, Steinman L (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8:500-508

    CAS  PubMed  Google Scholar 

  75. Lock CB, Heller RA (2003) Gene microarray analysis of multiple sclerosis lesions. Trends Mol Med 9:535-541

    CAS  PubMed  Google Scholar 

  76. Lovrecic L, Ristic S, Starcevic-Cizmarevic N, Jazbec SS, Sepcic J, Kapovic M, Peterlin B (2006) Angiotensin-converting enzyme I/D gene polymorphism and risk of multiple sclerosis. Acta Neurol Scand 114:374-377

    CAS  PubMed  Google Scholar 

  77. Lucchinetti CF, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for pathogenesis of demyelination. Ann Neurol 47:707-717

    CAS  PubMed  Google Scholar 

  78. Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallstrom E, Khademi M, Oturai A, Ryder LP, Saarela J, Harbo HF, Celius EG, Salter H, Olsson T, and Hillert J (2007) Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 39:1108-1113

    CAS  PubMed  Google Scholar 

  79. Maas K, Chan S, Parker J, Slater A, Moore J, Olsen N, Aune TM (2002) Cutting edge: molecular portrait of human autoimmune disease. J Immunol 169:5-9

    CAS  PubMed  Google Scholar 

  80. Mak TW, Simard JJL (1998) Handbook of immune response genes. New York, Plenum Press

    Google Scholar 

  81. Mandel M, Gurevich M, Pauzner R, Kaminski N, Achiron A (2004) Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus. Clin Exp Immunol 138:164-170

    CAS  PubMed  Google Scholar 

  82. Marrosu MG, Murru R, Murru MR, Costa G, Zavattari P, Whalen M, Cocco E, Mancosu C, Schirru L, Solla E, Fadda E, Melis C, Porru I, Rolesu M, Cucca F (2001) Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum Mol Genet 10:2907-2916

    CAS  PubMed  Google Scholar 

  83. Martins Silva B, Thorlacius T, Benediktsson K, Pereira C, Fossdal R, Jonsson HH, Silva A, Leite I, Cerqueira J, Costa PP, Marta M, Foltynie T, Sawcer S, Compston A, Jonasdottir A (2003) A whole genome association study in multiple sclerosis patients from north Portugal. J Neuroimmunol 143:116-119

    CAS  PubMed  Google Scholar 

  84. Martyn CN, Gale CR (1997) The epidemiology of multiple sclerosis. Acta Neurol Scand Suppl 169:3-7

    CAS  PubMed  Google Scholar 

  85. McElroy JP (2005) Mapping quantitative trait loci for economic traits in chickens. Genetics. PhD Thesis, Iowa State University, Ames, IA

    Google Scholar 

  86. Mirel DB, Barcellos LF, Wang J, Hauser SL, Oksenberg JR, Erlich HA (2004) Analysis of IL4R haplotypes in predisposition to multiple sclerosis. Genes Immun 5:138-141

    CAS  PubMed  Google Scholar 

  87. Modin H, Olsson W, Hillert J, Masterman T (2004) Modes of action of HLA-DR susceptibility specificities in multiple sclerosis. Am J Hum Genet 74:1321-1322

    CAS  PubMed  Google Scholar 

  88. Mumford CJ, Wood NW, Kellar-Wood H, Thorpe JW, Miller DH, Compston DA (1994) The British Isles survey of multiple sclerosis in twins. Neurology 44:11-15

    CAS  PubMed  Google Scholar 

  89. Mycko MP, Papoian R, Boschert U, Raine CS, Selmaj KW (2003) cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity. Brain 126:1048-1457

    PubMed  Google Scholar 

  90. Mycko MP, Papoian R, Boschert U, Raine CS, Selmaj KW (2004) Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis. Clin Neurol Neurosurg 106:223-229

    PubMed  Google Scholar 

  91. Nadeau JH, Lee C (2006) Genetics: copies count. Nature 439:798-799

    CAS  PubMed  Google Scholar 

  92. Oksenberg JR, Baranzini SE, Barcellos LF, Hauser SL (2001) Multiple sclerosis: genomic rewards. J Neuroimmunol 113:171-184

    CAS  PubMed  Google Scholar 

  93. Oksenberg JR, Barcellos LF (2005) Multiple sclerosis genetics: leaving no stone unturned. Genes Immun 6:375-387

    CAS  PubMed  Google Scholar 

  94. Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O, Lincoln RR, Swerdlin A, Mignot E, Lin L, Goodin D, Erlich HA, Schmidt S, Thomson G, Reich DE, Pericak-Vance MA, Haines JL, Hauser SL (2004) Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 74:160-167

    CAS  PubMed  Google Scholar 

  95. Oturai A, Larsen F, Ryder LP, Madsen HO, Hillert J, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Koch-Henriksen N, Sawcer S, Fugger L, Sorensen PS, Svejgaard A (1999) Linkage and association analysis of susceptibility regions on chromosomes 5 and 6 in 106 Scandinavian sibling pair families with multiple sclerosis. Ann Neurol 46:612-616

    CAS  PubMed  Google Scholar 

  96. Palacio LG, Rivera D, Builes JJ, Jimenez ME, Salgar M, Anaya JM, Jimenez I, Camargo M, Arcos-Burgos M, Sanchez JL (2002) Multiple sclerosis in the tropics: genetic association to STR’s loci spanning the HLA and TNF. Mult Scler 8:249-255

    CAS  PubMed  Google Scholar 

  97. Peiffer DA, Le JM, Steemers FJ, Chang W, Jenniges T, Garcia F, Haden K, Li J, Shaw CA, Belmont J, Cheung SW, Shen RM, Barker DL and Gunderson KL (2006) High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. Genome Res 16:1136-1148

    CAS  PubMed  Google Scholar 

  98. Pericak-Vance MA, Rimmler JB, Haines JL, Garcia ME, Oksenberg JR, Barcellos LF, Lincoln R, Hauser SL, Cournu-Rebeix I, Azoulay-Cayla A, Lyon-Caen O, Fontaine B, Duhamel E, Coppin H, Brassat D, Roth MP, Clanet M, Alizadeh M, Yaouanq J, Quelvennec E, Semana G, Edan G, Babron MC, Genin E, Clerget-Darpoux F (2004) Investigation of seven proposed regions of linkage in multiple sclerosis: an American and French collaborative study. Neurogenetics 5:45-48

    PubMed  Google Scholar 

  99. Pericak-Vance MA, Rimmler JB, Martin ER, Haines JL, Garcia ME, Oksenberg JR, Barcellos LF, Lincoln R, Goodkin DE, Hauser SL (2001) Linkage and association analysis of chromosome 19q13 in multiple sclerosis. Neurogenetics 3:195-201

    CAS  PubMed  Google Scholar 

  100. Rajda C, Bencsik K, Seres E, Jonasdottir A, Foltynie T, Sawcer S, Benediktsson K, Fossdal R, Setakis E, Compston A, Vecsei L (2003) A genome-wide screen for association in Hungarian multiple sclerosis. J Neuroimmunol 143:84-87

    CAS  PubMed  Google Scholar 

  101. Ramanathan M, Weinstock-Guttman B, Nguyen LT, Badgett D, Miller C, Patrick K, Brownscheidle C, Jacobs L (2001) In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects. J Neuroimmunol 116:213-219

    CAS  PubMed  Google Scholar 

  102. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, Fiegler H, Shapero MH, Carson AR, Chen W, Cho EK, Dallaire S, Freeman JL, Gonzalez JR, Gratacos M, Huang J, Kalaitzopoulos D, Komura D, MacDonald JR, Marshall CR, Mei R, Montgomery L, Nishimura K, Okamura K, Shen F, Somerville MJ, Tchinda J, Valsesia A, Woodwark C, Yang F, Zhang J, Zerjal T, Zhang J, Armengol L, Conrad DF, Estivill X, Tyler-Smith C, Carter NP, Aburatani H, Lee C, Jones KW, Scherer SW, Hurles ME (2006) Global variation in copy number in the human genome. Nature 444:444-454

    CAS  PubMed  Google Scholar 

  103. Reich D, Patterson N, De Jager PL, McDonald GJ, Waliszewska A, Tandon A, Lincoln RR, DeLoa C, Fruhan SA, Cabre P, Bera O, Semana G, Kelly MA, Francis DA, Ardlie K, Khan O, Cree BA, Hauser SL, Oksenberg JR, Hafler DA (2005) A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nat Genet 37:1113-1118

    CAS  PubMed  Google Scholar 

  104. Reunanen K, Finnila S, Laaksonen M, Sumelahti ML, Wikstrom J, Pastinen T, Kuokkanen S, Saarela J, Uimari P, Ruutiainen J, Ilonen J, Peltonen L, Tienari PJ (2002) Chromosome 19q13 and multiple sclerosis susceptibility in Finland: a linkage and two-stage association study. J Neuroimmunol 126:134-142

    CAS  PubMed  Google Scholar 

  105. Risch N (1990) Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 46:222-228

    CAS  PubMed  Google Scholar 

  106. Rubio JP, Bahlo M, Butzkueven H, van Der Mei IA, Sale MM, Dickinson JL, Groom P, Johnson LJ, Simmons RD, Tait B, Varney M, Taylor B, Dwyer T, Williamson R, Gough NM, Kilpatrick TJ, Speed TP, Foote SJ (2002) Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis. Am J Hum Genet 70:1125-1137

    CAS  PubMed  Google Scholar 

  107. Saarela J, Kallio SP, Chen D, Montpetit A, Jokiaho A, Choi E, Asselta R, Bronnikov D, Lincoln MR, Sadovnick AD, Tienari PJ, Koivisto K, Palotie A, Ebers GC, Hudson TJ and Peltonen L (2006) PRKCA and multiple sclerosis: association in two independent populations. PLoS Genet 2:e42

    Google Scholar 

  108. Saarela J, Schoenberg Fejzo M, Chen D, Finnila S, Parkkonen M, Kuokkanen S, Sobel E, Tienari PJ, Sumelahti ML, Wikstrom J, Elovaara I, Koivisto K, Pirttila T, Reunanen M, Palotie A, Peltonen L (2002) Fine mapping of a multiple sclerosis locus to 2.5 Mb on chromosome 17q22-q24. Hum Mol Genet 11:2257-2267

    CAS  PubMed  Google Scholar 

  109. Sadovnick AD, Armstrong H, Rice GP, Bulman D, Hashimoto L, Paty DW, Hashimoto SA, Warren S, Hader W, Murray T et al (1993) A population-based study of multiple sclerosis in twins: update. Ann Neurol 33:281-285

    CAS  PubMed  Google Scholar 

  110. Sadovnick AD, Baird PA, Ward RH (1988) Multiple sclerosis: updated risks for relatives. Am J Med Genet 29:533-541

    CAS  PubMed  Google Scholar 

  111. Sadovnick AD, Ebers GC, Dyment DA, Risch NJ (1996) Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet 347:1728-1730

    CAS  PubMed  Google Scholar 

  112. Santos M, Pinto-Basto J, Rio ME, Sa MJ, Valenca A, Sa A, Dinis J, Figueiredo J, Bigotte de Almeida L, Coelho I, Sawcer S, Setakis E, Compston A, Sequeiros J, Maciel P (2003) A whole genome screen for association with multiple sclerosis in Portuguese patients. J Neuroimmunol 143:112-115

    CAS  PubMed  Google Scholar 

  113. Satoh J, Nakanishi M, Koike F, Miyake S, Yamamoto T, Kawai M, Kikuchi S, Nomura K, Yokoyama K, Ota K, Kanda T, Fukazawa T, Yamamura T (2005) Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis. Neurobiol Dis 18:537-550

    CAS  PubMed  Google Scholar 

  114. Satoh J, Nakanishi M, Koike F, Onoue H, Aranami T, Yamamoto T, Kawai M, Kikuchi S, Nomura K, Yokoyama K, Ota K, Saito T, Ohta M, Miyake S, Kanda T, Fukazawa T, Yamamura T (2006) T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients. J Neuroimmunol 174:108-118

    CAS  PubMed  Google Scholar 

  115. Sawcer S, Ban M, Maranian M, Yeo TW, Compston A, Kirby A, Daly MJ, De Jager PL, Walsh E, Lander ES, Rioux JD, Hafler DA, Ivinson A, Rimmler J, Gregory SG, Schmidt S, Pericak-Vance MA, Akesson E, Hillert J, Datta P, Oturai A, Ryder LP, Harbo HF, Spurkland A, Myhr KM, Laaksonen M, Booth D, Heard R, Stewart G, Lincoln R, Barcellos LF, Hauser SL, Oksenberg JR, Kenealy SJ, Haines JL (2005) A high-density screen for linkage in multiple sclerosis. Am J Hum Genet 77:454-467

    PubMed  Google Scholar 

  116. Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J, Robertson N, Clayton D, Goodfellow PN, Compston A (1996) A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 13:464-468

    CAS  PubMed  Google Scholar 

  117. Sawcer S, Maranian M, Setakis E, Curwen V, Akesson E, Hensiek A, Coraddu F, Roxburgh R, Sawcer D, Gray J, Deans J, Goodfellow PN, Walker N, Clayton D, Compston A (2002) A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility. Brain 125:1337-1347

    PubMed  Google Scholar 

  118. Seldin MF, Shigeta R, Villoslada P, Selmi C, Tuomilehto J, Silva G, Belmont JW, Klareskog L, Gregersen PK (2006) European population substructure: clustering of northern and southern populations. PLoS Genet 2:e143

    Google Scholar 

  119. Shinar Y, Pras E, Siev-Ner I, Gamus D, Brautbar C, Israel S, Achiron A (1998) Analysis of allelic association between D6S461 marker and multiple sclerosis in Ashkenazi and Iraqi Jewish patients. J Mol Neurosci 11:265-269

    CAS  PubMed  Google Scholar 

  120. Sospedra M, Muraro PA, Stefanova I, Zhao Y, Chung K, Li Y, Giulianotti M, Simon R, Mariuzza R, Pinilla C, Martin R (2006) Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype. J Immunol 176:1951-1961

    CAS  PubMed  Google Scholar 

  121. Spurkland A, Ronningen KS, Vandvik B, Thorsby E, Vartdal F (1991) HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis. Hum Immunol 30:69-75

    CAS  PubMed  Google Scholar 

  122. Stoevring B, Frederiksen JL, Christiansen M (2007) CRYAB promoter polymorphisms: influence on multiple sclerosis susceptibility and clinical presentation. Clin Chim Acta 375:57-62

    CAS  PubMed  Google Scholar 

  123. Swanberg M, Lidman O, Padyukov L, Eriksson P, Akesson E, Jagodic M, Lobell A, Khademi M, Borjesson O, Lindgren CM, Lundman P, Brookes AJ, Kere J, Luthman H, Alfredsson L, Hillert J, Klareskog L, Hamsten A, Piehl F, Olsson T (2005) MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 37:486-494

    CAS  PubMed  Google Scholar 

  124. The International MS Genetics Consortium (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357:851-862

    Google Scholar 

  125. TMSGC (2001) A meta-analysis of genomic screens in multiple sclerosis. The Transatlantic Multiple Sclerosis Genetics Cooperative. Mult Scler 7:3-11

    Google Scholar 

  126. van Baarsen LG, van der Pouw Kraan TC, Kragt JJ, Baggen JM, Rustenburg F, Hooper T, Meilof JF, Fero MJ, Dijkstra CD, Polman CH, Verweij CL (2006) A subtype of multiple sclerosis defined by an activated immune defense program. Genes Immun 7:522-531

    CAS  Google Scholar 

  127. Vandenbroeck K, Fiten P, Heggarty S, Goris A, Cocco E, Hawkins SA, Graham CA, Marrosu MG, Opdenakker G (2002) Chromosome 7q21-22 and multiple sclerosis: evidence for a genetic susceptibility effect in vicinity to the protachykinin-1 gene. J Neuroimmunol 125:141-148

    CAS  PubMed  Google Scholar 

  128. Vyshkina T, Banisor I, Shugart YY, Leist TP, Kalman B (2005) Genetic variants of complex I in multiple sclerosis. J Neurol Sci 228:55-64

    CAS  PubMed  Google Scholar 

  129. Vyshkina T, Kalman B (2005) Haplotypes within genes of beta-chemokines in 17q11 are associated with multiple sclerosis: a second phase study. Hum Genet 118:67-75

    CAS  PubMed  Google Scholar 

  130. Weber A, Infante-Duarte C, Sawcer S, Setakis E, Bellmann-Strobl J, Hensiek A, Rueckert S, Schoenemann C, Benediktsson K, Compston A, Zipp F (2003) A genome-wide German screen for linkage disequilibrium in multiple sclerosis. J Neuroimmunol 143:79-83

    CAS  PubMed  Google Scholar 

  131. Whitney LW, Becker KG, Tresser NJ, Caballero-Ramos CI, Munson PJ, Prabhu VV, Trent JM, McFarland HF, Biddison WE (1999) Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays. Ann Neurol 46:425-428

    CAS  PubMed  Google Scholar 

  132. Whitney LW, Ludwin SK, McFarland HF, Biddison WE (2001) Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions. J Neuroimmunol 121:40-48

    CAS  PubMed  Google Scholar 

  133. Wise LH, Lanchbury JS, Lewis CM (1999) Meta-analysis of genome searches. Ann Hum Genet 63:263-272

    CAS  PubMed  Google Scholar 

  134. Xu C, Dai Y, Fredrikson S, Hillert J (1999) Association and linkage analysis of candidate chromosomal regions in multiple sclerosis: indication of disease genes in 12q23 and 7ptr-15. Eur J Hum Genet 7:110-116

    CAS  PubMed  Google Scholar 

  135. Xu C, Dai Y, Lorentzen JC, Dahlman I, Olsson T, Hillert J (2001) Linkage analysis in multiple sclerosis of chromosomal regions syntenic to experimental autoimmune disease loci. Eur J Hum Genet 9:458-463

    CAS  PubMed  Google Scholar 

  136. Yamasaki K, Horiuchi I, Minohara M, Kawano Y, Ohyagi Y, Yamada T, Mihara F, Ito H, Nishimura Y, Kira J (1999) HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain 122:1689-1696

    PubMed  Google Scholar 

  137. Yeo TW, Roxburgh R, Maranian M, Singlehurst S, Gray J, Hensiek A, Setakis E, Compston A and Sawcer S (2003) Refining the analysis of a whole genome linkage disequilibrium association map: the United Kingdom results. J Neuroimmunol 143:53-59

    CAS  PubMed  Google Scholar 

  138. Zhou Q, Rammohan K, Lin S, Robinson N, Li O, Liu X, Bai XF, Yin L, Scarberry B, Du P, You M, Guan K, Zheng P, Liu Y (2003) CD24 is a genetic modifier for risk and progression of multiple sclerosis. Proc Natl Acad Sci U S A 100:15041-15046

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, School of Medicine, University of California at San Francisco, San Francisco, CA 94143, USA

    J. P. McElroy & J. R. Oksenberg

Authors
  1. J. P. McElroy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. R. Oksenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurology and Immunology, Mayo Clinic, College of Medicine, 200 First Street SW, Rochester, MN 55905, USA

    Moses Rodriguez

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

McElroy, J.P., Oksenberg, J.R. (2008). Multiple Sclerosis Genetics. In: Rodriguez, M. (eds) Advances in multiple Sclerosis and Experimental Demyelinating Diseases. Current Topics in Microbiology and Immunology, vol 318. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-73677-6_3

Download citation

Publish with us

Policies and ethics

Search

Navigation